Skip to search formSkip to main contentSkip to account menu

Nexrutine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Muscle loss is a debilitating side effect to prostate cancer (PCa) experienced by nearly 60% of men. The purpose of this study… 
2018
2018
Oncologists encourage nutritional and physical interventions to improve outcomes in cancer patients with cachexia; however, it is… 
2017
2017
Lack of effective options following failure to conventional chemotherapeutic agent such as Docetaxel (DX) is a major clinical… 
2017
2017
Epidemiological data suggests that physical activity (PA) has the potential to decrease the risk of high-grade prostate cancer… 
2016
2016
Cachexia is a major adverse effect of prostate cancer (PCa) and leads to functional impairment and poor quality of life. The… 
2015
2015
Background/Aims: Nexrutine is an herbal extract of Phellodendron amurense and has been used as nutrient supplement in China as… 
2012
2012
Pancreatic cancer (PanCA) has the shortest 5-year survival of any solid tumor. It is critical to understand the molecular events… 
2011
2011
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Multiple myeloma (MM), a clonal malignancy of plasma…